Papers/PMID:38789831
Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study.
GeroScience2024The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
NMN zwitterion — decreases pittsburgh Sleep Quality Index global score
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“The NMN group had improved sleep quality at 12 weeks relative to the placebo group as evidenced by lower scores for "Daytime dysfunction" and "Global PSQI" on the Pittsburgh Sleep Questionnaire.”
Quoted verbatim from Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study.. - Study
- RCT
- Duration
- 3 months
- Dose
- 250 mg/day NMN for 12 weeks
- Population
- Older adults in a randomized, placebo-controlled, double-blind, parallel-group trial; NMN group versus placebo group at 12 weeks
Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study.2024PMID:38789831Permalink